Home » Topics » Regulatory » Patents

Patents
RSS

Novel VEGF inhibitors in development at Genentech

Feb. 18, 1998

No Comments

Merck describes dopamine D4 receptor ligands with therapeutic potential

Feb. 18, 1998

No Comments

Tyrosine kinase modulators under development by Yissum, Sugen

Feb. 18, 1998

No Comments

Substance P antagonists revealed by Boehringer Ingelheim

Feb. 18, 1998

No Comments

Warner-Lambert reveals new protein farnesyltransferase inhibitors

Feb. 17, 1998

No Comments

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Feb. 17, 1998

No Comments

SmithKline Beecham discovers nonpeptide G-CSF mimetics

Feb. 17, 1998

No Comments

New GnRH antagonists from Merck & Co.

Feb. 17, 1998

No Comments

Egis patents compounds affecting the central and peripheral serotonergic system

Feb. 16, 1998

No Comments

Nonpeptide GnRH antagonists disclosed by Merck & Co.

Feb. 16, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Patents
RSS

Novel VEGF inhibitors in development at Genentech

Merck describes dopamine D4 receptor ligands with therapeutic potential

Tyrosine kinase modulators under development by Yissum, Sugen

Substance P antagonists revealed by Boehringer Ingelheim

Warner-Lambert reveals new protein farnesyltransferase inhibitors

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

SmithKline Beecham discovers nonpeptide G-CSF mimetics

New GnRH antagonists from Merck & Co.

Egis patents compounds affecting the central and peripheral serotonergic system

Nonpeptide GnRH antagonists disclosed by Merck & Co.

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Patents RSS

Patents
RSS